The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person23

CervoMed Inc.

Company

14 records in the corpus

CERENOME, INC.

Company

11 records in the corpus

Cerence Inc.

Company

8 records in the corpus

Certara, Inc.

Company

6 records in the corpus

CEVA INC

Company

8 records in the corpus

INSMED Inc

Company

9 records in the corpus

CARLSMED, INC.

Company

9 records in the corpus

Ceribell, Inc.

Company

20 records in the corpus

IR-Med, Inc.

Company

1 records in the corpus

MED-X, INC.

Company

4 records in the corpus

PAVmed Inc.

Company

6 records in the corpus

Electromed, Inc.

Company

4 records in the corpus

RESMED INC

Company

8 records in the corpus

BirchBioMed Inc.

Company

2 records in the corpus

Cencora, Inc.

Company

16 records in the corpus

Apnimed, Inc.

Company

2 records in the corpus

MARIMED INC.

Company

12 records in the corpus

Cenntro Inc.

Company

4 records in the corpus

CEMTREX INC

Company

3 records in the corpus

CHS INC

Company

4 records in the corpus

CAE INC

Company

1 records in the corpus

Celcuity Inc.

Company

10 records in the corpus

CorMedix Inc.

Company

8 records in the corpus

Primary record7

CervoMed Inc. filed 8-K

Item 7.01. Regulation FD Disclosure. On October 29, 2026, CervoMed Inc. (the “Company”) issued a press release announcing the publication of two peer-reviewed research articles related to neflamapimod as a potential trea

29 Oct 2026 · sec daily index

CervoMed Inc. filed 4

SEC form 4 filed by CervoMed Inc. (CIK 1053691) on 2026-10-23.

23 Oct 2026 · sec daily index

CervoMed Inc. filed 4

SEC form 4 filed by CervoMed Inc. (CIK 1053691) on 2026-10-23.

23 Oct 2026 · sec daily index

CervoMed Inc. filed 4

SEC form 4 filed by CervoMed Inc. (CIK 1053691) on 2026-10-23.

23 Oct 2026 · sec daily index

CervoMed Inc. filed 8-K

Item 7.01. Regulation FD Disclosure. Certain information concerning the business, clinical studies, development plans, financial position, and related matters of CervoMed Inc. (the Company, we, or us ) is being made avai

14 Oct 2026 · sec daily index

CervoMed Inc. filed 8-K

Item 7.01. Regulation FD Disclosure. On October 12, 2026, CervoMed Inc. (the Company ) issued a press release announcing initial data from the first 12 weeks of the Company s Phase 2a clinical trial in nonfluent variant

13 Oct 2026 · sec daily index

CervoMed Inc. filed 8-K

Item 7.01. Regulation FD Disclosure. Certain information concerning the business, clinical studies, development plans, financial position, and related matters of CervoMed Inc. (the Company, we, or us ) is being made avai

09 Oct 2026 · sec daily index